| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 64,146 | |||
| Short-term investments | 163,022 | |||
| Prepaid expenses and other current assets | 18,138 | |||
| Total current assets | 245,306 | |||
| Total property and equipment | 3,359 | |||
| Less accumulated depreciation | 2,500 | |||
| Property and equipment, net | 859 | |||
| Restricted cash | 207 | |||
| Right of use asset | 5,710 | |||
| Other assets | 5,140 | |||
| Total assets | 257,222 | |||
| Accounts payable | 2,446 | |||
| Accrued expenses | 14,048 | |||
| Lease liability - current | 862 | |||
| Deferred grant earnings | 1,206 | |||
| Total current liabilities | 18,562 | |||
| Lease liability - noncurrent | 5,144 | |||
| Total long-term liabilities | 5,144 | |||
| Total liabilities | 23,706 | |||
| Redeemable convertible preferred stock-Series DRedeemable Convertible Preferred Stock | 198,870 | |||
| Redeemable convertible preferred stock-Series CRedeemable Convertible Preferred Stock | 224,992 | |||
| Redeemable convertible preferred stock-Series B1Redeemable Convertible Preferred Stock | 11,981 | |||
| Redeemable convertible preferred stock-Series BRedeemable Convertible Preferred Stock | 51,094 | |||
| Redeemable convertible preferred stock-Series A1Redeemable Convertible Preferred Stock | 15,963 | |||
| Redeemable convertible preferred stock-Series ARedeemable Convertible Preferred Stock | 4,793 | |||
| Additional paid-in capital | 6,749 | |||
| Accumulated other comprehensive income | 46 | |||
| Accumulated deficit | -280,972 | |||
| Total stockholders' deficit | -274,177 | |||
| Total liabilities, redeemable convertible preferred stock, and stockholders' deficit | 257,222 | |||
MapLight Therapeutics, Inc. (MPLT)
MapLight Therapeutics, Inc. (MPLT)